Related references
Note: Only part of the references are listed.The economic burden of progressive chronic kidney disease among patients with type 2 diabetes
Suma Vupputuri et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2014)
A Ligand-Independent VEGFR2 Signaling Pathway Limits Angiogenic Responses in Diabetes
Carmen M. Warren et al.
SCIENCE SIGNALING (2014)
Kidney Disease and Increased Mortality Risk in Type 2 Diabetes
Maryam Afkarian et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
FGF-23 and secondary hyperparathyroidism in chronic kidney disease
Justin Silver et al.
NATURE REVIEWS NEPHROLOGY (2013)
Risk of ESRD and All Cause Mortality in Type 2 Diabetes According to Circulating Levels of FGF-23 and TNFR1
Jung Eun Lee et al.
PLOS ONE (2013)
Longitudinal Progression Trajectory of GFR Among Patients With CKD
Liang Li et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes
Monika A. Niewczas et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Chronic Kidney Disease as a Coronary Disease Equivalent-A Comparison with Diabetes over a Decade
Yalew T. Debella et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States
Ian H. de Boer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Biomarkers in chronic kidney disease: a review
Robert G. Fassett et al.
KIDNEY INTERNATIONAL (2011)
The Emerging Role of Biomarkers in Diabetic and Hypertensive Chronic Kidney Disease
Kunal Chaudhary et al.
CURRENT DIABETES REPORTS (2010)
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial
George L. Bakris et al.
LANCET (2010)
Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study
Christopher Keller et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
The growing economic burden of diabetic kidney disease
Robert N. Foley et al.
CURRENT DIABETES REPORTS (2009)
Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease
Rajiv Agarwal et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The mild to moderate kidney disease (MMKD) study
Danilo Fliser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions
Enqi Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man
B Hohenstein et al.
KIDNEY INTERNATIONAL (2006)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study
WF Keane et al.
KIDNEY INTERNATIONAL (2003)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
